A Rational Design Approach for Developing Immunomodulators Based on CD4 and CD8

References

• Altman , J.D. , Moss , P.A. , Goulder , P.J. , Barouch , D.H. and McHeyzer-Williams , M.G. 1996 . Bell, J.I., McMichael, A.J. and Davis, M.M. Phenotypic analysis of antigen-specific T lymphocytes . Science , 274 : 94 – 96 .
   PubMed Web of Science ®Google Scholar
• Avidan , N. and Tumas-Brundage , K.M. 1995 . Sieck, T.G., Prystowsky, M.B. and Blank, K.J. Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+murine leukemia virus . Virology , 211 : 507 – 513 .
   PubMedGoogle Scholar
• Banner , D. 1993 . D’Arcy, A., Janes, W., Gentz, R., Schoenfeld, H., Broger, C., Loetscher, H. and Lesslauer, W. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation . Cell , 73 : 431 – 445 .
   PubMed Web of Science ®Google Scholar
• Boriack-Sjodin , P. 1998 . Margarit, S., Bar-Sagl D. and Kuriyan, J. The structural basis of the activation of Tas by Sos . Nature , 394 : 337 – 343 .
   PubMed Web of Science ®Google Scholar
• Breeveld , F. 2000 . Therapeutic monoclonal antibodies . Lancet , 355 : 735 – 740 .
   PubMedGoogle Scholar
• Brown , E.J. and Goodwin , J.L. 1988 . Fibronectin receptors of phagocytes. Characterization of the Arg-Gly-Asp binding proteins of human monocytes and polymorphonuclear leukocytes . Journal of Experimental Medicine , 167 : 777 – 793 .
   PubMed Web of Science ®Google Scholar
• Brown , J.H. , Jardetzky , T.S. , Gorga , J.C. , Stern , L.J. , Urban , R.G. , Strominger , J.L. and Wiley , D.C. 1993 . Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 . Nature , 364 : 33 – 39 .
   PubMed Web of Science ®Google Scholar
• Carteaux , J.P. , Roux , S. , Kuhn , H. , Tschopp , T. , Colombo , V. and Hadvary , P. 1993 . Ro 44–9883, a new nonpeptide glycoprotein IIb/IIIa antagonist, prevents platelet loss during experimental cardiopulmonary bypass . Journal of Thoracic Cardiovascular Surgery , 106 : 834 – 841 .
   PubMed Web of Science ®Google Scholar
• Cheng , Y.K. and Rossky , P.J. 1998 . Surface topography dependence of biomolecular hydrophobic hydration . Nature , 392 : 696 – 699 .
   PubMed Web of Science ®Google Scholar
• Chorev , M. 1979 . Shavitz, R., Goodman, M., Minick, S. and Guellemin, R. Partially modified retro-inverso-enkephalinamides: topochemical long-acting analogs in vitro and in vivo . Science , 204 : 1230 – 1212 .
   Google Scholar
• Colcher , D. , Pavlinkova , G. and Beresford , G. 1998 . Booth, B., Choudhury, A. and Batra, S. Pharmacokinetics and diodistrivution of genetically-engineered antibodies . Quarterly Journal of Nuclear Medicine , 42 : 225 – 241 .
   PubMedGoogle Scholar
• Craig , J.C. , Duncan , I.B. , Hockley , D. , Grief , C. , Roberts , N.A. and Mills , J.S. 1991 . Antiviral properties of Ro 31–8959, an inhibitor of human immunodeficiency virus (HIV) proteinase . Antiviral Research , 16 : 295 – 305 .
   PubMed Web of Science ®Google Scholar
• Degrado , W.F. 1988 . Design of peptides and proteins . Advances in Protein Chemistry , 39 : 51 – 124 .
   PubMedGoogle Scholar
• DeSolms , S.J. , Giuliani , E.A. , Guare , J.P. , Vacca , J.P. , Sanders , W.M. , Graham , S.L. , Wiggins , J.M. , Darke , P.L. , Sigal , I.S. and Zugay , J.A. 1991 . Design and synthesis of HIV protease inhibitors. Variations of the carboxy terminus of the HIV protease inhibitor L-682, 679 . Journal of Medicinal Chemistry , 34 : 2852 – 2857 .
   PubMedGoogle Scholar
• De Vos , A. 1992 . Ultsch, M. and Kossiakoff, A. Human growth hormone and extracellular domain of its receptor: crystal .structure of the complex . Science , 255 : 306 – 312 .
   PubMed Web of Science ®Google Scholar
• Diehl , L. 2000 . Den Boer, A., Van der Voort, E., Melief, C., Offringa, R. andToes, R. The role of CD40 in peripheral T cell tolerance and immunity . Journal of Molecular Medicine , 78 : 363 – 371 .
   PubMedGoogle Scholar
• Ensmingbr , S. , Witzke , O. and Sprjewald , B. 2000 . Morrison, K., morris, P., Rose, M. and Wood, K. CD8+T cells contribute to the development of transplant arteriosclerosis despite CD 154 blockade . Transplantation , 69 : 2609 – 2612 .
   PubMedGoogle Scholar
• Erickson , J. , Neidhart , D.J. and VanDrie , J. 1990 . Kempf, D.J., Wang, X.C., Norbeck, D.W., Plattner, J.J., Rittenhouse, J.W., Turon. M. and Wideburg, N. Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease . Science , 249 : 527 – 533 .
   PubMed Web of Science ®Google Scholar
• Flynn , K.J. , Riberdy , J.M. , Christensen , J.P. , Altman , J.D. and Doherty , P.C. 1999 . In vivo proliferation of naive and memory influenza-specific CD8(+) T cells . National Academy of Sciences of the United States of America. Proceedings , 96 : 8597 – 8602 .
   PubMed Web of Science ®Google Scholar
• Friedman , T.M. , Reddy , A.P. , Wassell , R. , Jameson , B.A. and Korngold , R. 1996 . Identification of a human CD4-CDR3-like surface involved in CD4+T cell function . Journal of Biological Chemistry , 271 : 22635 – 22640 .
   PubMedGoogle Scholar
• Gao , G.F. , Tormo , J. , Gerth , U.C. , Wyer , J.R. , McMichael , A.J. , Stuart , D.I. and Bell , J.I. 1997 . Jones, E. Y. and Jakobsen, B.K. Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2 . Nature , 387 : 630 – 634 .
   PubMedGoogle Scholar
• Graca , L. , Honey , K. and Adams , E. 2000 . Cobbold, S.P. and Waldmann, H. Anti-CD154 therapeutic antibodies induce infectious transplantation tolerance . Journal of Immunology , 165 : 4783 – 4786 .
   PubMedGoogle Scholar
• Hartman , G.D. , Egbertson , M.S. , Halczenko , W. , Laswell , W.L. , Duggan , M.E. , Smith , R.L. , Naylor , A.M. and Manno , P.D. 1992 . Lynch. R.J. and Zhang, G. Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors . Journal of Medicinal Chemistry , 35 : 4640 – 4642 .
   PubMed Web of Science ®Google Scholar
• Hillegass , W. and Newman , A. 1999 . Raco.D. Economic issues in glycoprotein Ilb/IIIa receptor therapy . American Heart Journal , 138 ( 1 Pt 2S ) : 24 – 32 .
   Google Scholar
• Honey , K. , Cobbold , S. and Waldmann , H. 1999 . CD40 ligand blockade induces CD4+T cell tolerance and linked suppression . Journal of Immunology , 163 : 4805 – 4810 .
   PubMedGoogle Scholar
• Hutchings , P. and Parish , N. 1993 . O’Reilly, L., Dawe, K., Roitt, I.M. and Cooke, A. The regulation of autoimmunity through CD4+T cells . Autoimmunity , 15 : 21 – 23 .
   PubMedGoogle Scholar
• Jameson , B.A. 1989 . Modeling and peptide design . Nature , 341 : 465 – 67 .
   PubMedGoogle Scholar
• Jameson , B.A. , McDonnell , J.M. , Marini , J.C. and Korngold , R. 1994 . A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis . Nature , 368 : 744 – 746 .
   PubMed Web of Science ®Google Scholar
• Janeway , C. A. 1992 . The Tceil receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation . Annual Review of Immunology , 10 : 645 – 674 .
   PubMed Web of Science ®Google Scholar
• Kenyon , N. , Chatzipetrou , M. and Masetti , M. 1999 . Ranucoli, A., Oliveira, M., Wagner, J., Kirk, A., Harlan, D., Vurkly, L. and Ricordi, C. Long-term survival and function of intrabepatic islet allografts in rhesus monkeys treated with humanized anti-CD154 . National Academy of Sciences of the United States of America. Proceedings , 96 : 8132 – 8136 .
   PubMed Web of Science ®Google Scholar
• Kern , P.S. , Teng , M.K. , Smolyar , A. , Liu , J.H. and Liu , J. 1998 . Hussey, R.E., Spoerl, R., Chang. H.C.Reinherz.E.L. and Wang, J.H. Structural basis of CD8 coreceptor function revealed by crystallographic analysis of a murine CD8 alphaalpha ectodomain fragment in complex with H-2Kb . Immunity , 9 : 519 – 530 .
   PubMedGoogle Scholar
• Kirk , A. , Burkly , L. and Batty , D. 1999 . Baumgartner, R., Berning. J.K.B., Fechner, J., Germond, R., Kampen, R., Patterson, N., Swanson, S., Tadaki, D., TenHoor, C., White, L., Knechtle, S. and HARLAN, D. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates . Nature Medicine , 5 : 686 – 693 .
   PubMed Web of Science ®Google Scholar
• Koch , U. and Korngold , R. 1997 . A synthetic CD4-CDR3 peptide analog enhances bone marrow engraftment across major histocompatibility barriers . Blood , 89 : 2880 – 2890 .
   PubMedGoogle Scholar
• Koch , U. , Choksi , S. , Marcucci , L. and Korngold , R. 1998 . A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier . Journal of Immunology , 161 : 421 – 29 .
   PubMedGoogle Scholar
• Kwong , P. , Wyatt , R. and Robinson , J. 1998 . Sweet, R., Sodroski, J. andHendrickson, W. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody . Nature , 393 : 648 – 659 .
   PubMed Web of Science ®Google Scholar
• Leahy , D.J. , Axel , R. and Hendrickson , W.A. 1992 . Crystal structure of a soluble form of the human T cell co-receptor CD8 at 2.6 angstroms . Cell , 68 : 1145 – 1153 .
   PubMedGoogle Scholar
• Lucchinetti , C. , Bruck , W. and Noseworthy , J. 2001 . Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment . Current Opinions in Neurology , 14 : 259 – 269 .
   PubMed Web of Science ®Google Scholar
• Marini , J.C. , Jameson , B.A. , Lublin , F.D. and Korngold , R. 1996 . A CD4-CDR3 peptide analog inhibits both primary and secondary autoreactive CD4+T cell responses in experimental allergic encephalomyelitis . Journal of Immunology , 157 : 3706 – 3715 .
   PubMedGoogle Scholar
• Markees , T. , Phillips , N. and Gordon , E. 1998 . Noelle, R., Shultz, L., Morders, J., Greiner, D. and Rossini, A. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4+T cells, interferongamma, and CTLA4 . Journal of Clinical Investigation , 101 : 2446 – 2452 .
   PubMed Web of Science ®Google Scholar
• Matsushita , S. 2000 . Current status and future issues in the treatment of HIV-1 infection . International Journal of Hematology , 72 : 20 – 27 .
   PubMed Web of Science ®Google Scholar
• McDonnell , J.M. , Blank , K.J. , Rao , P.E. and Jameson , B.A. 1992a . Direct involvement of the CDR3-like domain of CD4 in T helper cell activation . Journal of Immunology , 149 : 1626 – 1630 .
   PubMedGoogle Scholar
• McDonnell , J.M. , Varnum , J.M. , Mayo , K.H. and Jameson , B.A. 1992b . Rational design of a peptide analog of the L3T4 CDR3-like region . Immunomethods , 1 : 33 – 39 .
   Google Scholar
• Okamoto , S. , Watanabe , M. and Yamazaki , M. 1999 . Yajima, T., Hayashi, T., Ishii, H., Mukai, M., Yamada, T., Watanabe, N., Jameson, B.A. and Hibi, T. A synthetic mimetic of CD4 is able to suppress disease in a rodent model of immune colitis . European Journal of immunology , 29 : 355 – 366 .
   PubMed Web of Science ®Google Scholar
• Panoutsakopoulou , V. , Littls , C.S. , Sieck , T.G. , Blankenhorn , E.P. and Blank , K.J. 1998 . Differences in the immune response during the acute phase of E-55+Murine Leukemia Virus infection in progressor BALB and long term nonprogressor C57BL mice . Journal of Immunology , 161 : 17 – 26 .
   PubMedGoogle Scholar
• Pardanani , A. , Gambacurta , A. , ASCOLI , F. and Royer , W.E. 1998 . Mutational destabilization of the critical interface water cluster in Scapharca dimeric hemoglobin: structural basis for altered allosteric activity . Journal of ‘Molecular Biology , 284 : 729 – 739 .
   PubMedGoogle Scholar
• Pierschbacher , M.D. and Ruoslahti , E. 1984 . Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule . Nature , 309 : 30 – 33 .
   PubMed Web of Science ®Google Scholar
• Reddy , M.R. , Viswanadhan , V.N. and Weinstein , J.N. 1991 . Relative differences in the binding free energies of human immunodeficiency virus 1 protease inhibitors: a thermodynamic cycle-perturbation approach . National Academy of Sciences of the United States of America. Proceedings , 88 : 10287 – 10291 .
   PubMedGoogle Scholar
• Rirringer , K. , Walker , P. , Eccleston , J. and Smerdon , S. 1997 . and Gamblin, S.Structure at 1.65A of RhoA and its GTPase-activating protein in complex with a transition-state analogue . Nature , 389 : 758 – 762 .
   PubMedGoogle Scholar
• Rolak , L.A. 2001 . Multiple sclerosis treatment 2001 . Neurology Clinic , 19 : 107 – 118 .
   PubMedGoogle Scholar
• Ryu , S.E. , Kwong , P.D. , Truneh , A. , Porter , T.G. and Arthos , J. 1990 . Rosenberg, M., Dai, X.P., Xuong, N.H., Axel, R. and Sweet, R.W. Crystal structure of an HIV-binding recombinant fragment of human CD4 . Nature , 348 : 419 – 426 .
   PubMed Web of Science ®Google Scholar
• Thaisrivongs , S. , Tomasselli , A.G. , Moon , J.B. and Hui , J. 1991 . McQuade, T.J., Turner, S.R., Strohbach, J.W., Howe, W.J., Tarpley, W.G. and Heinrikson, R.L. Inhibitors of the protease from human immunodeficiency virus: design and modeling of a compound containing a dihydroxyethylene isostere insert with high binding affinity and effective antiviral activity . Journal of Medicinal Chemistry , 34 : 2344 – 2356 .
   PubMedGoogle Scholar
• Townsend , R.M. and Briggs , C. 1996 . Marini J.C., Murphy, G.F. and Korngold, R. Inhibitory effect of a CD4-CDR3 peptide analog on graft-versus-host disease across a major histocompatibility complex-haploidentical barrier . Blood , 88 : 3038 – 3047 .
   PubMedGoogle Scholar
• Townsend , R.M. 1998 . Gilbert. M.J. and Korngold, R. Combination therapy with a CD4-CDR3 peptide analog and cyclosporin A to prevent graft-vs-host disease in a MHC-haploidenlical bone marrow transplantation model . Clinical Immunology and Immunopathology , 86 : 115 – 119 .
   PubMedGoogle Scholar
• Tretiakova , A.P. , Little , C.S. , Blank , K.J. and Jameson , B.A. 2000 . Rational design of cytotoxic T-cell inhibitors . Nature Biotechnology , 18 : 984 – 988 .
   PubMedGoogle Scholar
• Wlodawer , A. , Miller , M. and Jaskolski , M. 1989 . Sathyanarayana, B.K., Baldwin, E., Weber, I.T., Selk, L.M., Clawson, L., Schneider, J. and Kent, S.B. Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease . Science , 245 : 616 – 621 .
   PubMed Web of Science ®Google Scholar